Latest News
Curasight reports encouraging preliminary Phase 1 data for uTREAT in glioblastoma
...
Alvotech reports FDA review acceptance for Entyvio biosimilar candidate AVT16
8 June 2026 - Global biotechnology company Alvotech S.A. (NASDAQ:ALVO) announced on Monday that the US Food and Drug Administration (FDA) has accepted for review its Biologics License Application for AVT16, a proposed interchangeable biosimilar to En...
Sanofi secures EU approval for subcutaneous Sarclisa with on-body injector
8 June 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Monday that it has received European Commission approval for subcutaneous Sarclisa (isatuximab) for multiple myeloma across all existing indications cu...
Sciwind Biosciences reports positive study data on ecnoglutide versus semaglutide
8 June 2026 - Hangzhou Sciwind Biosciences Co Ltd, a China-based, commercial-stage biopharmaceutical company focused on discovering and developing innovative therapies for metabolic diseases, announced on Sunday that key data from a head-to-head stud...
Antengene presents first ATG-207 preclinical data at EULAR 2026
8 June 2026 - Commercial-stage biotech company Antengene Corporation Limited (SEHK:6996) announced on Sunday that it has presented the first preclinical data on ATG-207, alpha masked and TGF beta RIII-biased CD3-TGF-beta bifunctional fusion protein i...